David A. Siegel Replimune Group, Inc. Call Options Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding REPL
# of Institutions
154Shares Held
66.1MCall Options Held
79.4KPut Options Held
102K-
Baker Bros. Advisors LP New York, NY9.55MShares$77.4 Million0.99% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.55MShares$53.1 Million0.01% of portfolio
-
State Street Corp Boston, MA6.49MShares$52.6 Million0.0% of portfolio
-
Fcpm Iii Services B.V. Naarden, P74.87MShares$39.5 Million5.62% of portfolio
-
Black Rock Inc. New York, NY4.61MShares$37.4 Million0.0% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $400M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...